title: Apolipoprotein AI is a serum and tissue marker of liver fibrosis in alcoholic patients.
abstract: The aim of this study was to assess the specific correlation of apolipoprotein-AI to hepatic fibrosis in alcoholic patients. Four hundred eighty two patients were prospectively included with serum measurement of apolipoprotein-AI within 10 days before liver biopsy. Pathologic features were semiquantitatively assessed by two observers. In 28 patients liver biopsy was used for histomorphometric assessment of fibrosis and immunohistochemical labeling of apolipoprotein-AI. Serum apolipoprotein-AI was negatively correlated to semiquantitative score of fibrosis (r = -0.50; p less than 0.001), independently of the scores of steatosis and alcoholic hepatitis (r = -0.44; p less than 0.001) and of the value of serum albumin, bilirubin, and prothrombin time (r = -0.22; p less than 0.001) and independently of the nutritional parameters (r = -0.29; p less than 0.009). The mean value of apolipoprotein-AI decreased according to the grade of fibrosis from 220 +/- 6 mg/dl (mean +/- SEM) to 110 +/- 8 mg/dl. Serum apolipoprotein-AI was negatively correlated to the percentage of fibrosis (r = -0.70; p less than 0.001) in the biopsies morphometrically assessed. The labeling was superimposed to the extracellular matrix. In conclusion, this study shows that decrease of apolipoprotein-AI is a serum and tissue marker of liver fibrosis independently of steatosis, alcoholic hepatitis, liver function tests, and nutritional parameters.
authors.affiliation: Antoine Béclère Hospital, Clamart, France.
authors.forename: P
authors.initials: P
authors.lastname: Bedossa
authors.forename: T
authors.initials: T
authors.lastname: Poynard
authors.forename: A
authors.initials: A
authors.lastname: Abella
authors.forename: A
authors.initials: A
authors.lastname: Aubert
authors.forename: J P
authors.initials: JP
authors.lastname: Pignon
authors.forename: S
authors.initials: S
authors.lastname: Naveau
authors.forename: R
authors.initials: R
authors.lastname: Leluc
authors.forename: G
authors.initials: G
authors.lastname: Lemaigre
authors.forename: E D
authors.initials: ED
authors.lastname: Martin
authors.forename: J C
authors.initials: JC
authors.lastname: Chaput
mesh_terms: D016632:Apolipoprotein A-I; D001054:Apolipoproteins A / Q000032:analysis*; D001055:Apolipoproteins B / Q000032:analysis; D015415:Biomarkers / Q000032:analysis; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D008104:Liver Cirrhosis, Alcoholic / Q000175:diagnosis* / Q000378:metabolism; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D011168:Portal System / Q000473:pathology
chemical_list: D016632:Apolipoprotein A-I; D001054:Apolipoproteins A; D001055:Apolipoproteins B; D015415:Biomarkers